Understanding torsade de pointes: a bridge to tailored drug therapy?

Cardiovasc Drugs Ther. 2002 Mar;16(2):87-8. doi: 10.1023/a:1015781429700.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Humans
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / genetics
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / drug therapy
  • Torsades de Pointes / genetics

Substances

  • Anti-Arrhythmia Agents